Marker Therapeutics, Inc. (MRKR) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Marker Therapeutics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -1.88x | -2.60x | -5.88x | -0.74x | -1.74x | -2.38x |
| P/B Ratio | 0.00x | 1.50x | 3.45x | 1.13x | 1.65x | 2.49x |
| P/S Ratio | 6.43x | 4.24x | 14.63x | 6.32x | 58.55x | 146.12x |
| Profitability | ||||||
| Gross Margin | 0.0% | -104.3% | -214.6% | -240.6% | -154.7% | -3944.9% |
| Operating Margin | -350.7% | -168.7% | -440.4% | -563.3% | -3179.3% | -6188.3% |
| Net Margin | -343.0% | -162.8% | -248.8% | -851.9% | -3372.7% | -6149.7% |
| EBITDA Margin | -350.7% | -168.7% | -356.1% | -483.9% | -3118.0% | -5919.2% |
| Liquidity | ||||||
| Current Ratio | 8.39x | 6.36x | 5.57x | 2.14x | 3.56x | 3.81x |
| Quick Ratio | 8.39x | 6.36x | 5.89x | 2.14x | 3.56x | 3.81x |
| Leverage | ||||||
| Debt/Equity | 0.00x | 0.00x | 0.00x | 0.39x | 0.27x | 0.45x |
YoY = year-over-year change. Source: FMP..